Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Alla
Alla Danilkovich, Columbia, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100068191 | PURIFIED MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF PURIFYING MESENCHYMAL STEM CELL COMPOSITIONS - One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed. | 03-18-2010 |
Alla Dyachenko, Bucha UA
| Patent application number | Description | Published |
|---|---|---|
| 20100261029 | MULTI-PHASE PARTICULATES, METHOD OF MAKING, AND COMPOSITION CONTAINING SAME - Provided is a multi-phase particulate having a dispersed phase component dispersed in and bound to a bulk phase component. The dispersed phase component includes a metal, a metal oxide, an organometallic compound, salts thereof, and/or mixtures thereof, and the bulk phase component includes an inorganic material different from the dispersed phase component. The dispersed phase component is present in an amount ranging from 0.5 to 60 percent by weight based on total combined weight of the dispersed phase component and the bulk phase component. Related methods, compositions and composites also are provided. | 10-14-2010 |
Alla Gorina, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100179911 | COLLATERAL VALIDATION SYSTEM - The present invention is directed to a collateral validation system, and method providing an approach to automating valuation reconciliation. The collateral validation system is a fully automated validation of past and current valuations as well as allowing for forecasting future collateral values. It incorporates multiple independent opinions of value using a panel of experts approach employing multiple sub models along with housing price indices (HPIs), neighborhood level home price indices, premier data, external factors, analytics and predictive modeling, to enable a consensus approach, foreclosure trends, and external factors all user selectable and user weight adjustable for varying use configurations. As a result, a user may obtain a full and complete determination and validation of past and present value along with forecasted values coupled with statistical analyses in a fully customizable environment. | 07-15-2010 |
Alla Khanmamedova, Sugar Land, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110132804 | Increasing octane number of light naphtha using a germanium-zeolite catalyst - This invention relates to a process for the increasing the octane number of a naphtha hydrocarbon feed having a predominantly paraffin content with a germanium-containing zeolite catalyst. The catalyst is a non-acidic germanium zeolite on which a noble metal, such as platinum, has been deposited. The zeolite structure may be of MTW, MWW, MEL, TON, MRE, FER, MFI, BEA, MOR, LTL or MTT. The zeolite is made non-acidic by being base-exchanged with an alkali metal or alkaline earth metal, such as cesium, potassium, sodium, rubidium, barium, calcium, magnesium and mixtures thereof, to reduce acidity. The catalyst is sulfur tolerant. The hydrocarbon feed may contain sulfur up to 1000 ppm. The present invention could be applicable to a feedstream which is predominantly naphthenes and paraffins. | 06-09-2011 |
Alla Oleinikova, Bochum DE
| Patent application number | Description | Published |
|---|---|---|
| 20100058782 | ADSORBER AND ITS USE IN HEAT ACCUMULATORS AND HEAT PUMPS, OR REFRIGERATORS - The invention relates to an adsorbent having a porous carrier structure, the pore walls of which are coated with a material which displays a temperature-induced reversible switching-over of the surface properties from hydrophilic to hydrophobic behaviour, the hydrophobicity increasing with rising temperature. | 03-11-2010 |
Alla Polozova, Cranberry, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090191259 | Efficient liposomal encapsulation - The present invention concerns a method for preparing liposomes, said method comprising the following steps: (I) mixing at least one liposome-forming lipid, a water-miscible organic solvent and aqueous medium Y to form a gel or liquid containing gel particles without sonication; and thereafter (II) (a) mixing the gel or liquid containing gel particles with aqueous medium Z1 to directly form the liposomes; (b) (i) mixing the gel or liquid containing gel particles with aqueous medium Z1 to form a curd or curdy substance; and (ii) mixing the curd or curdy substance with aqueous medium Z2 to directly form the liposomes; or (c) (i) cooling the gel or liquid containing gel particles to form a waxy substance; and (ii) mixing the waxy substance with aqueous medium Z1 to directly form the liposomes; wherein aqueous media Y, Z1 and Z2 are the same or different. | 07-30-2009 |
Alla Romashko, Lexington, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110318327 | TREATMENT OF SANFILIPPO SYNDROME TYPE B - Among other things, the present invention provides methods and compositions of treating Sanfilippo syndrome type B (Sanfilippo B) by, e.g., intrathecal (IT) administration of a Naglu protein. A suitable Naglu protein can be a recombinant, gene-activated or natural protein. In some embodiments, a suitable Naglu protein is a recombinant Naglu protein. In some embodiments, a recombinant Naglu protein is a fusion protein containing a Naglu domain and a lysosomal targeting moiety. In some embodiments, the lysosomal targeting domain is an IGF-II moiety. | 12-29-2011 |
Alla Sarafeddinov, Heppenheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20100275380 | AGENT AND METHOD FOR TANNING SKINS AND PELTS - Process for the tanning of hides and skins, characterized in that hides and skins are treated with tanning agents containing deglycosylated iridoids and/or deglycosylated secoiridoids, excluding tanning agents containing genipin. | 11-04-2010 |
Alla Skapenko, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20120014956 | METHODS AND COMPOSITIONS FOR PREDICTING RESPONSIVENESS TO TREATMENT WITH TNF-ALPHA INHIBITOR - The invention provides methods of determining or predicting the responsiveness of a subject to treatment with a TNFα inhibitor, such as a TNFα antibody by determining genetic factors. | 01-19-2012 |
Alla Skapenko, Erlangen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090148843 | Means and Methods for the Prediction of Joint Destruction - The present invention relates to a method of diagnosing and/or predicting joint destruction, early joint destruction and/or accelerated joint destruction in particular, in rheumatoid arthritis, comprising determining in a sample obtained from an individual the presence of at least one nucleic acid sequence encoding an IL-4 receptor (IL-4R) which contains a mutation in position 465 of the nucleotide sequence of the wild-type IL4R as shown in SEQ ID NO: 1, whereby at said position the nucleotide A is replaced or a nucleic acid sequence encoding an IL-4 receptor (IL-4R), said IL-4R comprising at position 75 as shown in SEQ ID NO: 2 a valine instead of an isoleucine. Furthermore, the invention provides for a method of diagnosing and/or predicting early joint destruction and/or accelerated joint destruction comprising determining in a sample obtained from an individual the presence of an encoded IL-4 receptor (IL-4R) which comprises at the homologous position 75 of IL-4 receptor as depicted in SEQ ID NO: 2 a mutation, said mutation comprising the exchange from an isoleucine to a valine. In addition, the present invention relates to a use of specific probes and/or primers for the preparation of a diagnostic composition for diagnosing and/or predicting early joint destruction and/or accelerated joint destruction in particular in rheumatoid arthritis. | 06-11-2009 |
Alla Soudakovitch, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20110023757 | METHOD AND SYSTEM FOR LOCALLY CONTROLLING SUPPORT OF A FLAT OBJECT - A non-contact support platform system is provided for supporting a substantially flat object. The system includes a platform with a first plurality of pressure ports and a first plurality of vacuum ports for inducing a fluid cushion to support the object at a distance from the platform. The system further includes a second plurality of pressure ports located at a predetermined zone of the platform for increasing the distance of the object from the platform at the predetermined zone. | 02-03-2011 |
Alla Tsipenyuk, Woodbridge, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110137701 | METHOD FOR VARYING RESOURCES AT A CALL CENTER BASED UPON PREDICTED CALL CENTER VOLUME - A computer method that is used to control call center volumes for a range of dates. The method involves utilizing previous mailing campaign and call center response data to determine when the mail arrives in the home and when a call center is contacted in response to information in the mail; predicting the call center volumes based initially on the previous campaign and call center response data and as the mailing campaign and call center responses progresses updating call center predictions based on current mailing campaign data; and determining in home mail volumes needed to control call center volumes. | 06-09-2011 |
Alla Zenova, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20100099728 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. | 04-22-2010 |
| 20100137299 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. | 06-03-2010 |
| 20110112162 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. | 05-12-2011 |